Factsheet for MBS item 73344

This page contains a factsheet on chnges to MBS item 73344 from 1 August 2020.

Page last updated: 31 July 2020

From 1 August 2020, Medicare Benefits Schedule (MBS) item 73344 for FISH testing for ROS1 gene rearrangements in patients with locally advanced or metastatic NSCLC, is changing to to enable testing to determine eligibility for entrectinib.

The below factsheet provides further guidance on this change.

In this section